The Trail Leading Back to the Wuhan Labs
https://www.nationalreview.com/2020/04/coronavirus-china-trail-leading-back-to-wuhan-labs/It is understandable that many would be wary of the notion that the origin of the coronavirus could be discovered by some documentary filmmaker who used to live in China. Matthew Tye, who creates YouTube videos, contends he has identified the source of the coronavirus — and a great deal of the information that he presents, obtained from public records posted on the Internet, checks out.
The Wuhan Institute of Virology in China indeed posted a job opening on November 18, 2019, “asking for scientists to come research the relationship between the coronavirus and bats.”
It gets more interesting.
On February 4 — one week before the World Health Organization decided to officially name this virus “COVID-19” — the journal Cell Research posted a notice written by scientists at the Wuhan Institute of Virology about the virus, concluding, “our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro. Since these compounds have been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease.” One of the authors of that notice was the “bat woman,” Shi Zhengli.
In his YouTube video, Tye focuses his attention on a researcher at the Wuhan Institute of Virology named Huang Yanling: “Most people believe her to be patient zero, and most people believe she is dead.”
There was enough discussion of rumors about Huang Yanling online in China to spur an official denial. On February 16, the Wuhan Institute of Virology denied that patient zero was one of their employees, and interestingly named her specifically: “Recently there has been fake information about Huang Yanling, a graduate from our institute, claiming that she was patient zero in the novel coronavirus.” Press accounts quote the institute as saying, “Huang was a graduate student at the institute until 2015, when she left the province and had not returned since. Huang was in good health and had not been diagnosed with disease, it added.” None of her publicly available research papers are dated after 2015.
Before President Donald Trump touted chloroquine to treat COVID-19 patients, it was used in China, along with remdesivir.
